These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3547029)

  • 21. Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients.
    Delemarre FG; Stevenhagen A; Kroon FP; van Eer MY; Meenhorst PL; van Furth R
    Immunology; 1994 Dec; 83(4):646-50. PubMed ID: 7875745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of the toxoplasmastatic activity of monocytes from AIDS patients during in vivo treatment with interferon-gamma.
    Delemarre FG; Stevenhagen A; Snijders F; Kroon FP; van Eer MY; Reiss P; van Furth R
    J Infect Dis; 1993 Aug; 168(2):516-8. PubMed ID: 8336000
    [No Abstract]   [Full Text] [Related]  

  • 23. TGF-β in Toxoplasmosis: Friend or foe?
    Zare-Bidaki M; Assar S; Hakimi H; Abdollahi SH; Nosratabadi R; Kennedy D; Arababadi MK
    Cytokine; 2016 Oct; 86():29-35. PubMed ID: 27449809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The virulence of toxoplasma].
    de Roever-Bonnet H
    Ned Tijdschr Geneeskd; 1966 Aug; 110(34):1495-7. PubMed ID: 5914942
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of monocytes in models of infection by protozoan parasites.
    Hu S; Wei W; Korner H
    Mol Immunol; 2017 Aug; 88():174-184. PubMed ID: 28704704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment in vitro of immunity against Toxoplasma gondii.
    Jones TC; Len L; Hirsch JG
    J Exp Med; 1975 Feb; 141(2):466-82. PubMed ID: 1113065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of circulating Toxoplasma gondii antigens by the dot-ELISA method].
    Bitkowska E; Dzbeński TH
    Wiad Parazytol; 1989; 35(4):283-8. PubMed ID: 2815756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effect of Toxoplasma gondii infection on adhesion capacity of fibroblasts and monocytes.
    Pfaff AW; Georges S; Candolfi E
    Parasite Immunol; 2008 Sep; 30(9):487-90. PubMed ID: 18627508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of dendritic cells in chicken spleen cell preparations and their functional interaction with the parasite Toxoplasma gondii.
    Quéré P; Pierre J; Hoang MD; Esnault E; Domenech J; Sibille P; Dimier-Poisson I
    Vet Immunol Immunopathol; 2013 May; 153(1-2):57-69. PubMed ID: 23477930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Sabin-Feldman dye test using T. gondii tachyzoites from animal inoculation still the best method for detecting Toxoplasma gondii antibodies?
    Udonsom R; Buddhirongawatr R; Sukthana Y
    Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1059-64. PubMed ID: 21073025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging and the immune response. II. Lymphocyte responsiveness and macrophage activation in Toxoplasma gondii-infected mice.
    Gardner ID; Remington JS
    J Immunol; 1978 Mar; 120(3):944-9. PubMed ID: 632594
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.
    Ryning FW; Krahenbuhl JL; Remington JS
    Immunology; 1981 Apr; 42(4):513-9. PubMed ID: 7239556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a novel 40,000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages.
    Reichmann G; Stachelhaus S; Meisel R; Mévélec MN; Dubremetz JF; Dlugonska H; Fischer HG
    Immunology; 1997 Oct; 92(2):284-9. PubMed ID: 9415038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of those components of Toxoplasma gondii responsible for delayed hypersensitivity reactions in mice.
    Lai CH; Tizard IR; Quinn PJ; Ingram DG
    Immunology; 1975 Apr; 28(4):611-20. PubMed ID: 1150310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune response in toxoplasmosis after mucosal immunization with Toxoplasma gondii antigens].
    Kobets NV; Zaĭtseva LG; Goncharov DB; Gubareva EV; Mezentseva MV; Kireeva IV; Surgucheva IM; Samoĭlenko II
    Med Parazitol (Mosk); 2010; (1):10-4. PubMed ID: 20361628
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of normal and activated human macrophages on Toxoplasma gondii.
    Anderson SE; Remington JS
    J Exp Med; 1974 May; 139(5):1154-74. PubMed ID: 4132992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogeny and immunological control of toxoplasmosis.
    Derouin F
    Braz J Med Biol Res; 1992; 25(12):1163-9. PubMed ID: 1341911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigens of Toxoplasma gondii].
    Długońska H; Dytnerska K
    Wiad Parazytol; 2000; 46(3):327-34. PubMed ID: 16883687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of effector functions in populations of activated macrophages.
    Wing EJ; Gardner ID; Ryning FW; Remington JS
    Nature; 1977 Aug; 268(5621):642-4. PubMed ID: 895861
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of white rat macrophages against Toxoplasma gondii in vitro].
    Chinchilla M; Guerrero OM; Solano E
    Rev Latinoam Microbiol; 1981; 23(4):239-43. PubMed ID: 7348321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.